GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Aethlon Medical
Aethlon Medical is developing a medical device for filtering viruses and cancer exosomes from blood. Its stock price represents a venture bet on this unique technology. The stock price reflects high volatility and dependence on clinical data news.
Share prices of companies in the market segment - Therapeutic medical equipment
Aethlon Medical is a medical company that developed the Hemopurifier hemofilter, which is designed to remove viruses and other harmful particles from blood. We classified it as "Therapeutic Medical Equipment." The chart below shows how the market evaluates innovative blood purification technologies.
Broad Market Index - GURU.Markets
Aethlon Medical is a medical device company that developed the Hemopurifier, a device for filtering viruses and other harmful particles from blood. It is a component of the GURU.Markets index. The chart below represents the market. See how this stock compares to the medical device sector.
Change in the price of a company, segment, and market as a whole per day
AEMD - Daily change in the company's share price Aethlon Medical
Aethlon Medical, Inc.'s daily stock price fluctuations reflect volatility in the medical device sector. This metric measures the company's sensitivity to news about the clinical application of its blood purification device.
Daily change in the price of a set of shares in a market segment - Therapeutic medical equipment
Aethlon Medical is developing a hemofiltration device, the Hemopurifier, to remove viruses and cancer exosomes from blood. This is an innovative medical technology. The chart below shows the volatility in the therapeutic device sector, reflecting the risks and potential associated with AEMD's developments.
Daily change in the price of a broad market stock, index - GURU.Markets
Aethlon Medical has developed a device for purifying blood of viruses and cancer exosomes. Shares of this innovative medtech company are responding to clinical successes and regulatory decisions, contributing to the overall volatility of the healthcare sector.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Aethlon Medical
Aethlon Medical's year-over-year performance is the story of its unique medical device, the Hemopurifier®. Its 12-month market cap depends entirely on clinical trial data, where it must prove that its device can effectively filter viruses and cancer exosomes from the blood, potentially leading to a breakthrough in the treatment of many diseases.
Annual dynamics of market capitalization of the market segment - Therapeutic medical equipment
Aethlon, a company developing a blood purification device, is betting on medical innovation. Its performance relative to the sector will reveal how much investors believe in its ability to commercialize its unique technology and secure regulatory approval.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Aethlon Medical, with its unique blood filtration device, has been a story of finding its niche for years. Its volatile performance compared to the market is a graph of investor hopes and disappointments. Growth comes from news of potential applications, while declines stem from a lack of commercial success.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Aethlon Medical
Aethlon Medical is developing a medical device for purifying blood of viruses and cancer exosomes. Its monthly growth depends entirely on progress in clinical trials and government contracts, particularly in the field of biodefense.
Monthly dynamics of market capitalization of the market segment - Therapeutic medical equipment
Aethlon Medical has developed the Hemopurifier, a medical device for filtering viruses and cancer exosomes from blood. The company's technology could become a breakthrough in the treatment of serious diseases. The chart below reflects the general sentiment in the therapeutic medical device sector, where investors are seeking new breakthrough technologies.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Aethlon Medical is developing a medical device for filtering viruses and cancer exosomes from blood. The company's shares are driven by news of clinical trials and regulatory approvals. Their performance is completely uncorrelated with the market and is a bet on a breakthrough in medical technology.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Aethlon Medical
Shares of Aethlon Medical, which develops a device for purifying blood of viruses and cancer particles, are extremely volatile. Weekly price movements depend entirely on clinical trial results and news about the potential use of their technology in pandemics. The chart below shows how short-term scientific developments and investor expectations influence the stock.
Weekly dynamics of market capitalization of the market segment - Therapeutic medical equipment
Aethlon Medical has developed a device for purifying blood of viruses and cancer particles. This is a breakthrough technology with broad potential applications. The chart below shows how news about clinical applications and regulatory approvals impact the company's shares, creating its own investment profile.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Aethlon Medical develops medical equipment. This chart compares its weekly performance to the broader market. It helps understand whether the company is moving in tandem with the medtech sector or whether its shares are more sensitive to news about clinical trials and regulatory decisions.
Market capitalization of the company, segment and market as a whole
AEMD - Market capitalization of the company Aethlon Medical
Aethlon Medical's valuation chart reflects its years-long efforts to commercialize its Hemopurifier device for purifying blood of viruses and cancer exosomes. Its market cap reflects how investors value this technology, which, despite its long history, is still struggling to gain widespread acceptance and approval.
AEMD - Share of the company's market capitalization Aethlon Medical within the market segment - Therapeutic medical equipment
Aethlon Medical's market share in the medical equipment sector is based on its unique Hemopurifier hemofiltration technology. Its market share is based on the device's ability to remove viruses and cancer-associated exosomes from the blood, which could become a breakthrough therapy for a wide range of diseases.
Market capitalization of the market segment - Therapeutic medical equipment
Here's a chart of the total market capitalization of companies developing blood purification devices. Aethlon Medical is a pioneer in this field with its hemopurifier. The graph shows how the market values technologies that can fight viruses and cancer by filtering blood.
Market capitalization of all companies included in a broad market index - GURU.Markets
This chart depicts the market value of a unique medical technology. Aethlon Medical's market capitalization is the valuation of its Hemopurifier device, designed to purify blood of viruses and cancer particles. The line shows how this bold idea is competing for its share of the future of global medicine.
Book value capitalization of the company, segment and market as a whole
AEMD - Book value capitalization of the company Aethlon Medical
This is an assessment of Aethlon Medical's assets. The chart reflects the value of its manufacturing capacity and, more importantly, the patents for the Hemopurifier® device for filtering viruses and tumor exosomes from blood. The growth of this line reflects the investment in this unique therapeutic technology.
AEMD - Share of the company's book capitalization Aethlon Medical within the market segment - Therapeutic medical equipment
Aethlon Medical's tangible assets include its R&D center and manufacturing facilities for the Hemopurifier device, designed to purify blood of viruses and toxins. The chart shows the company's share of this unique therapeutic infrastructure.
Market segment balance sheet capitalization - Therapeutic medical equipment
Amid the capital-intensive pharmaceutical industry, Aethlon Medical has chosen to create medical devices. Its business requires certified manufacturing facilities to produce its hemofilters, making its model moderately capital-intensive.
Book value of all companies included in the broad market index - GURU.Markets
Aethlon Medical is developing a "hemocorrector"—a medical device that filters viruses and cancer-associated exosomes from the blood. The company's assets include the technology and manufacturing capabilities for creating these "pathogen traps." The chart below shows the material value of this unique medical technology.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Aethlon Medical
Aethlon Medical has developed a medical device for removing viruses and cancer exosomes from the blood. Its market capitalization reflects the value of this unique technology and its potential for treating a wide range of diseases.
Market to book capitalization ratio in a market segment - Therapeutic medical equipment
Aethlon Medical, Inc. is developing a medical device for filtering viruses and cancer exosomes from blood. Its value lies in this unique technology. This chart shows how the market valuation, reflecting the potential of this therapeutic platform, relates to its tangible assets.
Market to book capitalization ratio for the market as a whole
Aethlon Medical is developing a hemopurifier—a medical device for purifying blood of viruses and cancer exosomes. The company's market valuation, shown on this chart, is based on the potential of this unique technology. The trend reflects investor expectations for clinical trials and potential applications in the treatment of various diseases.
Debts of the company, segment and market as a whole
AEMD - Company debts Aethlon Medical
Aethlon Medical, a company developing a medical device to filter viruses and cancer exosomes from blood, is using raised capital to fund its clinical trials. This chart shows how the company is spending funds on R&D and obtaining regulatory approvals for its unique therapeutic platform.
Market segment debts - Therapeutic medical equipment
Aethlon Medical has developed a unique medical device, Hemopurifier, for filtering viruses and cancer exosomes from blood. This chart shows how the company's debt policy, which is in clinical trials, reflects its capital needs to prove the effectiveness of its technology and obtain regulatory approval for market launch.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Aethlon Medical
SaverOne (2014) is developing technology to prevent drivers from using mobile phones while driving. This chart shows how the tech startup uses capital to refine its product, commercialize it, and market it to automakers and insurance companies, which requires significant effort.
Market segment debt to market segment book capitalization - Therapeutic medical equipment
Aethlon Medical develops hemofiltration devices designed to remove viruses and cancer exosomes from blood. This chart compares the company's debt load to the overall market capitalization of the entire sector. It shows how the clinical-stage company is financing its innovative, yet uncommercialized, technology.
Debt to book value of all companies in the market
Aethlon Medical is developing a medical device to filter viruses and cancer exosomes from blood. This innovative technology requires extensive clinical trials and regulatory approval. This graph of total market debt helps us understand the financial environment in which the company is seeking capital to commercialize its unique therapeutic approach.
P/E of the company, segment and market as a whole
P/E - Aethlon Medical
This chart shows the valuation of Aethlon Medical, a company developing a medical blood filtration device. P/E ratios are not applicable here. The company's valuation is a bet that its unique technology will be effective in removing viruses and other harmful particles and will be approved by regulators.
P/E of the market segment - Therapeutic medical equipment
Aethlon Medical has developed the Hemopurifier, a medical hemofiltration device designed to remove viruses and cancer-associated exosomes from the blood. This technology is suitable for the treatment of life-threatening diseases. This chart shows the average rating for the therapeutic device sector, reflecting how the market values breakthrough blood purification technologies.
P/E of the market as a whole
Aethlon Medical is developing the Hemopurifier, a hemofilter designed to remove viruses and cancer exosomes from blood. This technology could be used to treat life-threatening diseases. This risk appetite chart helps understand how investors value companies with breakthrough, yet early-stage, medical technologies.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Aethlon Medical
Aethlon Medical is developing the Hemopurifier medical device for filtering viruses and cancer exosomes from blood. This chart shows market expectations for the success of this innovative technology. Future revenue depends on clinical trial results and regulatory approval.
%20P%2FE%20Aethlon%20Medical&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Aethlon-Medical&v=1772606939634 "Chart of the company's future (projected) P/E Aethlon Medical")
Future (projected) P/E of the market segment - Therapeutic medical equipment
Aethlon Medical is developing a medical device, Hemopurifier, to filter viruses and cancer exosomes from blood. This chart reflects how investors view the potential of this breakthrough technology, which has not yet proven its broad effectiveness. It compares Aethlon's hopes with those of other companies developing innovative therapeutic devices.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Therapeutic-medical-equipment&v=1772606939707 "Future (projected) P/E graph of the market segment - Therapeutic medical equipment")
Future (projected) P/E of the market as a whole
Aethlon Medical is developing a medical device, Hemopurifier, for filtering viruses and cancer exosomes from blood. The company's success depends on clinical trial results and regulatory approval. The overall market optimism, as demonstrated by this chart, is important for attracting the investment needed to bring such breakthrough medical technologies to market.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772606939724 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Aethlon Medical
Aethlon Medical is developing the Hemopurifier medical device for filtering viruses and cancer exosomes from blood. Currently in clinical trials, the company is incurring significant R&D expenditures. This chart shows the company's financial trajectory, whose future profitability depends on regulatory approval and proof of its unique technology.
Profit of companies in the market segment - Therapeutic medical equipment
Aethlon Medical is developing the Hemopurifier® medical device for filtering viruses and cancer exosomes from blood. This graph, showing overall sector revenue, highlights the potential for breakthrough therapeutic technologies. Success in Aethlon's clinical trials could lead to the creation of a new treatment platform for multiple diseases and revolutionize the industry.
Overall market profit
Aethlon Medical has developed the Hemopurifier medical device for filtering viruses and cancer exosomes from blood. This innovative technology has potential for use in the treatment of many diseases. The company's success depends on the results of clinical trials and regulatory approvals.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Aethlon Medical
Aethlon Medical is developing a medical device, Hemopurifier, to filter viruses and cancer exosomes from blood. The revenue estimates you see are speculative and depend on the results of clinical trials and regulatory approval. The graph reflects the expected potential of this innovative technology.
%20profit%20of%20the%20company%20Aethlon%20Medical&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Aethlon-Medical&v=1772606939796 "Graph of future (projected) profit of the company Aethlon Medical")
Future (predicted) profit of companies in the market segment - Therapeutic medical equipment
Aethlon Medical is developing the Hemopurifier medical device for filtering viruses and cancer exosomes from blood. This chart shows revenue forecasts for the therapeutic medical device sector. It allows one to assess how the company's unique technology, a platform for treating various diseases, compares to general medical trends.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Therapeutic-medical-equipment&v=1772606939819 "Graph of future (predicted) profits of companies in a market segment - Therapeutic medical equipment")
Future (predicted) profit of the market as a whole
Aethlon Medical is developing a medical device for filtering viruses and cancer exosomes from blood. This innovative technology requires clinical validation. This chart, reflecting market sentiment, is important for Aethlon. During periods of growth, investors are more inclined to invest in breakthrough medical technologies with high risk but also high potential.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772606939824 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Aethlon Medical
Aethlon Medical is developing a medical device, the Hemopurifier, to filter viruses and cancer exosomes from blood. For a company with an innovative but not yet widely deployed technology, this chart is a sign of hope. It shows how investors view the potential of their device for treating life-threatening conditions, not current sales volumes.
P/S market segment - Therapeutic medical equipment
Aethlon Medical is developing the Hemopurifier® medical device, designed to remove viruses and cancer exosomes from blood. This technology could be a breakthrough in the treatment of viral infections and cancer. This chart shows the market premium for revenue in the innovative medical device sector, demonstrating confidence in the potential of Aethlon's platform.
P/S of the market as a whole
Aethlon Medical develops the Hemopurifier, a medical device—a hemofilter for removing cancer-causing viruses and exosomes from the blood. This chart, showing the average revenue estimate, emphasizes that investors value Aethlon based on the potential of its unique technology, not its current financial results.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Aethlon Medical
Aethlon Medical is developing the Hemopurifier medical device for removing viruses and oncogenic particles from blood. This chart shows investors' estimates of its potential future revenue from sales of the device. It reflects the market's confidence in the success of clinical trials and the commercialization of this innovative therapeutic platform.
%20P%2FS%20Aethlon%20Medical&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Aethlon-Medical&v=1772606939869 "The graph of the company's future (projected) P/S Aethlon Medical")
Future (projected) P/S of the market segment - Therapeutic medical equipment
Aethlon Medical is developing a medical device, Hemopurifier, for filtering viruses and cancer exosomes from blood. The chart shows the average estimated future revenue for therapeutic device manufacturers. It helps understand how investors value this unique technology and its potential to treat life-threatening diseases compared to similar technologies.
%20P%2FS%20market%20segment%20graph%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Therapeutic-medical-equipment&v=1772606939875 "Future (projected) P/S market segment graph - Therapeutic medical equipment")
Future (projected) P/S of the market as a whole
Aethlon Medical (AEMD) is developing the Hemopurifier medical device for filtering viruses and cancer exosomes from blood. Its potential depends on the success of clinical trials and regulatory approval. This graph does not reflect its unique prospects in the field of therapeutic filtration, which is independent of economic cycles.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772606939879 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Aethlon Medical
Aethlon Medical is in the development and clinical trials of its unique medical technology. The company is creating a hemofilter to remove viruses and cancer exosomes from the blood. Currently, it has no stable sales revenue, and its income comes from grants and contracts funding its cutting-edge research.
Sales of companies in the market segment - Therapeutic medical equipment
Aethlon Medical has developed a medical device, Hemopurifier, for filtering viruses and cancer exosomes from blood. Currently in clinical trials, the company does not yet have stable revenue. Its future revenue will depend on the successful approval and clinical implementation of this unique technology.
Overall market sales
Aethlon Medical, Inc. develops medical devices for filtering viruses and cancer exosomes from blood. As a development-stage company, its success depends on clinical trial results and approvals. This timeline, reflecting the overall economic situation, affects the availability of capital for funding breakthrough but risky medical technologies that require extensive research.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Aethlon Medical
Aethlon Medical is developing the Hemopurifier medical device for filtering viruses and cancer exosomes from blood. Future revenue depends on the success of clinical trials and regulatory approvals. This chart represents analysts' long-term view of the commercial potential of this innovative blood purification technology.
%20sales%20of%20the%20company%20Aethlon%20Medical&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Aethlon-Medical&v=1772606939929 "Schedule of future (projected) sales of the company Aethlon Medical")
Future (projected) sales of companies in the market segment - Therapeutic medical equipment
Aethlon Medical is developing the "Hemopurifier," a medical device for filtering viruses and cancer exosomes from blood. This graph shows the forecast for the therapeutic medical equipment sector. It reflects the demand for innovative treatments for life-threatening conditions, which is the basis for Aethlon's extracorporeal therapy technology.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Therapeutic-medical-equipment&v=1772606939973 "Schedule of future (projected) sales of companies in the market segment - Therapeutic medical equipment")
Future (projected) sales of the market as a whole
Investments in innovative medical technologies, which can be projected from this graph, determine the prospects of Aethlon Medical. The company develops devices for purifying blood of viruses and cancer markers. Funding for such developments depends on the influx of capital into the sector, which increases with economic growth.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772606939993 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Aethlon Medical
Aethlon Medical is developing a medical device, Hemopurifier, for filtering viruses and cancer exosomes from blood. This chart reflects the company's financial performance at the clinical trial stage. Future profitability depends entirely on regulatory approvals and demonstration of the clinical efficacy of this innovative technology.
Market segment marginality - Therapeutic medical equipment
Aethlon Medical is developing the Hemopurifier, a medical device designed to remove viruses and other harmful particles from blood. The company's profitability depends on obtaining regulatory approvals and implementing this technology into clinical practice. This chart shows the average profitability in the sector, helping to assess the commercial potential of its unique technology.
Market marginality as a whole
Aethlon Medical develops medical devices for filtering viruses and cancer exosomes from blood. As a research-stage company, it relies on funding and successful clinical data. This chart reflects the overall investment climate. It shows whether investors have the risk appetite to support the development of breakthrough, but not yet commercialized, medical technologies.
Employees in the company, segment and market as a whole
Number of employees in the company Aethlon Medical
Aethlon Medical is developing a medical device, Hemopurifier, to filter viruses and cancer exosomes from blood. This graph reflects a compact team of scientists and engineers. A small staff is typical for companies whose technology is in clinical trials. Growth will indicate progress in research and progress toward commercialization.
Share of the company's employees Aethlon Medical within the market segment - Therapeutic medical equipment
Aethlon Medical has developed the Hemopurifier, a medical device for filtering viruses and cancer exosomes from blood. This graph shows the company's share of the total number of specialists in the therapeutic apheresis niche. This reflects its unique technology and potential for treating a wide range of life-threatening conditions.
Number of employees in the market segment - Therapeutic medical equipment
Aethlon Medical is developing the Hemopurifier® medical device for filtering viruses and cancer exosomes from blood. This graph, illustrating employment in the therapeutic medical device sector, is important. The growing number of engineers and clinicians in this field speaks to the search for innovative treatments for life-threatening conditions, which is at the core of Aethlon's mission.
Number of employees in the market as a whole
Aethlon Medical is developing a medical device for purifying blood of viruses and cancer particles. Implementing such breakthrough technologies requires significant investment from the healthcare system. This overall occupancy rate reflects the economic stability that provides funding for hospitals and allows them to purchase innovative life-saving equipment.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Aethlon Medical (AEMD)
Aethlon Medical develops medical blood purification devices (hemopurifiers) for the treatment of cancer and viral infections. This chart reflects the value of their unique technology. The company's value comes from the patents for their Hemopurifier device. The market appreciates the medical potential of this development, supported by a relatively small R&D team.
%20of%20the%20company%20Aethlon%20Medical%20(AEMD)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Aethlon-Medical-AEMD&v=1772606940333 "Chart of market capitalization per employee (in thousands of dollars) of the company Aethlon Medical (AEMD)")
Market capitalization per employee (in thousands of dollars) in the market segment - Therapeutic medical equipment
Aethlon Medical develops medical devices for filtering blood from viruses and cancer markers. The company's value lies in its unique, patented Hemopurifier technology. This metric demonstrates how the market values breakthrough innovations in medicine, where a small team of engineers and scientists can create a product with enormous potential value.
%20by%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Therapeutic-medical-equipment&v=1772606940381 "Market capitalization per employee (in thousands of dollars) by market segment - Therapeutic medical equipment")
Market capitalization per employee (in thousands of dollars) for the overall market
Aethlon Medical is developing the Hemopurifier medical device for filtering viruses and cancer exosomes from blood. This is an innovative medical technology. The high employee rating, shown in this graph, reflects the enormous potential of this platform for treating a wide range of diseases, created by a small scientific and engineering team.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772606940422 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Aethlon Medical (AEMD)
Aethlon Medical is the developer of the Hemopurifier, a medical device for filtering viruses and exosomes from blood. This is a breakthrough technology, but one that is difficult to commercialize. This graph shows the company's costs: it reflects the costs (negative profit) for each employee (scientist, engineer) involved in long-term clinical trials and R&D.
%20Chart%20Aethlon%20Medical%20(AEMD)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Aethlon-Medical-AEMD&v=1772606940518 "Company Profit Per Employee (in thousands of dollars) Chart Aethlon Medical (AEMD)")
Profit per employee (in thousands of dollars) in the market segment - Therapeutic medical equipment
Aethlon Medical develops medical devices for filtering blood from viruses and cancer markers. For a company whose technology is in clinical trials and pending approval, this chart demonstrates the company's capital efficiency. Future growth is directly dependent on the successful commercialization of their flagship product, Hemopurifier.
%20in%20the%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Therapeutic-medical-equipment&v=1772606940538 "Chart of profit per employee (in thousands of dollars) in the market segment - Therapeutic medical equipment")
Profit per employee (in thousands of dollars) for the market as a whole
Aethlon Medical (AEMD) is the developer of the Hemopurifier, a medical device for filtering viruses and exosomes from blood. It is a MedTech company in the R&D and clinical trials stages. It is not profitable. This indicator is negative and represents the "cost" of one employee working on this unique medical technology.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772606940558 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Aethlon Medical (AEMD)
Aethlon Medical is developing the Hemopurifier medical device for filtering viruses and cancer exosomes from blood. This chart shows the company's progress in commercializing its unique technology. Revenue growth will depend on successful clinical trials and regulatory approvals.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Aethlon-Medical-AEMD&v=1772606940588 "Sales chart per company employee Aethlon Medical (AEMD)")
Sales per employee in the market segment - Therapeutic medical equipment
Aethlon Medical is the company behind the Hemopurifier, a medical device for filtering viruses and cancer exosomes from blood. They are an R&D company on the road to commercialization. This chart shows their progress. The productivity of their team of engineers and doctors is measured by their progress toward FDA approval.
Sales per employee for the market as a whole
Lucky Strike Entertainment (LUCK) (part of Bowlero Corp) is more than just a bowling alley; it's an "entertainment center" combining bowling, arcades, and premium food and beverage options. It's a business built on experience and service. The hospitality and entertainment industry requires a significant staff. This chart shows how successfully the company maximizes revenue per square foot and per guest by managing staff efficiency.
Short shares by company, segment and market as a whole
Shares shorted by company Aethlon Medical (AEMD)
Aethlon Medical (AEMD) has been developing "Hemoabsorbent"—a blood filter for the treatment of viruses and cancer—for many years. This chart shows the volume of short positions. The bears are betting that this technology, despite decades of work, has yet to prove its clinical effectiveness and remains speculative.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Aethlon-Medical-AEMD&v=1772606940675 "Short Shares Chart for the Company Aethlon Medical (AEMD)")
Shares shorted by market segment - Therapeutic medical equipment
Aethlon Medical (AEMD) is developing a medical device (Hemopurifier) for filtering viruses and exosomes from blood. The chart below shows the overall short position in the medical equipment sector. It illustrates how skeptical investors are about the commercialization of new blood purification technologies.
Shares shorted by the overall market
Aethlon Medical is developing the "Hemopurifier"—a device for filtering viruses and exosomes from blood. It's a breakthrough, but speculative, technology. This chart reflects general fear. When investors are fearful, they don't want to wait for long FDA approvals. They're selling off AEMD shares, fearing the company won't have enough cash to complete trials amid a market downturn.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Aethlon Medical (AEMD)
This chart for Aethlon Medical is an indicator of faith in blood purification technology. The company is developing the Hemopurifier, a filter that removes viruses and tumor markers from blood. "Overheating" (above 70) occurs during pandemics (COVID, Ebola) or due to positive data. The lack of FDA approval and market skepticism keep the stock "oversold."
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Aethlon-Medical-AEMD&v=1772606940729 "RSI 14 indicator chart for the company's stock Aethlon Medical (AEMD)")
RSI 14 Market Segment - Therapeutic medical equipment
Aethlon Medical is a medical technology company. They developed the Hemopurifier, a hemodialysis cartridge that filters cancer-associated viruses and exosomes from the blood. This is cutting-edge R&D. This chart measures the overall momentum in the therapeutic medical device sector. It helps assess whether this entire innovative segment is overheated.
RSI 14 for the overall market
Aethlon Medical (AEMD) develops medical devices to filter blood from viruses and cancer markers. This is an innovative but risky field. This market "temperature" chart shows when investors are willing to take risks (euphoria) or when they are panicking and fleeing risky assets (oversold). For AEMD, which relies on capital for R&D, this is a critical sentiment indicator.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast AEMD (Aethlon Medical)
Aethlon Medical (AEMD) has developed the Hemopurifier, a medical device for filtering viruses and exosomes from blood. This chart shows the average 12-month forecast. It reflects analysts' speculative assessment of this technology and its chances of receiving FDA approval for the treatment of cancer or viral infections.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-AEMD-Aethlon-Medical&v=1772606940812 "A chart showing analyst consensus forecasts for the expected stock price. AEMD (Aethlon Medical)")
The difference between the consensus estimate and the actual stock price AEMD (Aethlon Medical)
Aethlon Medical (AEMD) is a medical technology company that has developed the Hemopurifier, a filter that "fishes" viruses and cancer-causing exosomes directly from blood. This chart shows how the current share price differs from the "fair" value predicted by analysts. It reflects their faith in this breakthrough R&D platform.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-AEMD-Aethlon-Medical&v=1772606940837 "A chart showing the difference between the consensus forecast and the actual stock price. AEMD (Aethlon Medical)")
Analyst consensus forecast for stock prices by market segment - Therapeutic medical equipment
Aethlon Medical is a medical company that has developed a "blood filter" (Hemopurifier) that removes viruses and exosomes (associated with cancer) from the bloodstream. This chart shows general expectations for the therapeutic medical device sector. It reflects whether experts believe in this "blood purification" technology.
Analysts' consensus forecast for the overall market share price
Aethlon Medical (AEMD) is a blood "filter." They developed the Hemopurifier, a medical device that "catches" viruses and cancer exosomes directly from the bloodstream. This is breakthrough, but speculative, R&D. This chart shows the overall risk appetite. It reflects the market's willingness to fund breakthrough, but extremely risky, R&D projects.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Aethlon Medical
Aethlon Medical is an R&D company working on a blood filter. Their signature product is the Hemopurifier, a medical device designed to filter viruses and exosomes (which cause cancer) directly from a patient's blood. This chart is a clear indicator of their faith in R&D. It doesn't reflect revenue, but rather a speculative assessment of their (very risky) pipeline and their chances of FDA approval.
AKIMA Market Segment Index - Therapeutic medical equipment
Aethlon Medical has developed a unique therapeutic device, the Hemopurifier. It's essentially a blood filter that can remove viruses and cancer-causing exosomes. This cutting-edge technology is cutting-edge. This chart compares their composite index to the sector, showing how their innovative medical equipment outperforms the competition.
The AKIM Index for the overall market
Aethlon Medical is a medtech company developing the Hemopurifier device for purifying blood of viruses and cancer-related exosomes. This chart, which reflects the market average, is a backdrop. It helps assess how this therapeutic technology compares to overall macroeconomic trends and regulatory progress.
